"We are in an absolutely new" pandemic "phase, which we could define today as
'Covid-23'
, in which the virus, while persisting, is heading towards an
endemization phase
".
This is the awareness that emerged during the inauguration meeting of the international scientific board of the
Lazzaro Spallanzani National Institute of Infectious Diseases
in Rome made up of leading experts on the Covid-19 pandemic and on infectious diseases which took place this morning in the presence
by the Minister of Health Orazio Schillaci.
The "super team", strongly desired by the general manager
Francesco Vaia
will be coordinated by
Guido Silvestri
, pro-rector at Emory University in Atlanta, USA.
"With this event and the inauguration of such a
prestigious board of scientists
- declared Vaia - Spallanzani's scientific strengthening process and its international vocation are consolidated. Furthermore, its function at the service of the person and the institutions is confirmed ".
"This conference is particularly important because - underlined
Minister Schillaci
- with an international board of the highest level, it puts the Irccs Spallanzani of our national health system at the center of the prevention of possible future pandemics, after the "national institute of infectious diseases of Rome "has been
a fundamental bulwark in the past years precisely for the fight against Covid-19
. Therefore a continuity in excellence, testified by the scientific event that we are going to develop today".
Numerous guests were present, including the president of the Italian drug agency Aifa
Giorgio Palù
who commented: "With the international profile, research can progress and go forward".
"After the fight against the pandemic" of Covid-19, the Spallanzani Institute in Rome wants to become "the world stage to
truly go 'beyond the courtyard'
, for
an international and One Health vision
"- Vaia underlined.- "A panel of great international scientists and of our country - he explained - together to discuss the tools to fight this pandemic and the future of any possible other diseases ".